Eden Research plc

September 27, 2011 02:00 ET

Licence agreement signed with Cornell University

                                                                                     27 September 2011
                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")

                           Licence agreement signed with Cornell University

Eden  Research  plc, a leading UK agrochemical and encapsulation development company,  is  pleased  to
announce  that  it  has signed an exclusive licence agreement with Cornell University  ("Cornell")  of
Ithaca, USA.

The  agreement provides Eden with the exclusive rights to commercialise and sub-licence terpene  based
formulations relating to certain insecticidal applications.

Clive  Newitt, Managing Director of Eden, said, "Having worked on this project with Cornell  over  the
past  few  years, we are pleased that this agreement has come to fruition as it will  enable  Eden  to
fully exploit this particular sector where we know our products and technology are very effective  and
where demand for effective, naturally derived products, such as ours, is high."

The Directors of Eden are responsible for the contents of this announcement.


Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl


Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk

For more information about Eden, please visit www.edenresearch.com

Contact Information

  • Eden Research plc